GENERAL INFORMATION
PATRONAGE
CONGRESS VENUE
Porto Antico di Genova Centro Congressi
16128 Genova • Italy
Tel. (+39) 010 2485611
Fax (+39) 010 2758929
Università degli Studi di Genova
HOW TO REACH GENOA
• By plane: "Cristoforo Colombo" Airport, Genoa
• By train: "Genova Principe" railway station
• By car: Highways A7, A10 (exit Genova Ovest and then
follow the indications to Porto Antico)
REGISTRATION FEE
150,00 Euro (VAT included) for under 30 and postgraduated students
370,00 Euro (VAT included) for others
The registration fee includes:
• Admission to all the scientific sessions
• CME accreditation
• Congress kit
CME
The Meeting has been submitted for approval for continuing
education units to the Italian Health Ministry.
ERA - EDTA
Società Italiana Medicina Interna
PRESIDENT
G. Deferrari
Di.M.I.
Università di Genova
SCIENTIFIC COMMITTEE
G. Deferrari, C. Borghi, D. De Zeeuw, P. Fioretto,
F. Locatelli, R. Pontremoli, A. Salvetti, M. Volpe, C. Zoccali
GENOA MEETING
ON
HYPERTENSION,
DIABETES
AND
RENAL DISEASES
SCIENTIFIC SECRETARIAT
Di.M.I.
Università di Genova
U.O. Clinica Nefrologica, Dialisi e Trapianto
IRCCS Azienda Ospedaliera Universitaria
San Martino - IST Istituto Nazionale per la Ricerca sul Cancro
Largo Rosanna Benzi, 10 • 16132 Genova • Italy
Tel. (+39) 010 3537972 • Fax (+39) 010 5535970
E-mail genoameeting@aristea.com
OFFICIAL LANGUAGES
The official language of the Congress is English.
ORGANIZING SECRETARIAT
WEB SITE
The congress page is available on the web at the following
address: www.genoameeting.org
Via Roma, 10 • 16121 Genova • Italy
Tel. (+39) 010 553591 • Fax (+39) 010 5535970
E-mail genova@aristea.com • Web www.aristea.com
PRELIMINARY PROGRAMME
PORTO ANTICO DI GENOVA
CENTRO CONGRESSI, ITALY
FEBRUARY 20 -22, 2014
P r
P ROGRAM
S CIENTIFIC C OMMITTEE
o g r a m
12.30
Thursday, February 20, 2014
Giacomo Deferrari
Paola Fioretto
Francesco Locatelli
15.00
Opening Remarks
15.30
LECTURE SESSION
Chairmen: D. Di Landro, L. Gesualdo
• Emerging Technologies in dialysis: do they
really impact on outcome? - C. Tetta
• The heart as a biomarker of global
cardiovascular risk in CKD - E. Paoletti
• New therapeutic strategies
in the diabetic patient - P. Fioretto
Massimo Volpe
Roberto Pontremoli
Claudio Borghi
Antonio Salvetti
Carmine Zoccali
17.00
P RELIMINARY FACULTY
E. Agabiti Rosei
E. Ambrosioni
M. Azizi
A. Bellasi
C. Borghi
G. Capasso
G. Deferrari
G. Desideri
D. Di Landro
C. Ferri
P. Fioretto
L. Gesualdo
G. Grassi
F. Locatelli
G. London
G. Mancia
P. Messa
A. Morganti
F. Moirano
M.L. Muiesan
S. Nuti
E. Paoletti
G. Parati
R. Pontremoli
A. Salvetti
A. Santoro
G. Schillaci
A. Stella
S. Taddei
C. Tetta
J.M. Titze
B. Trimarco
F. Viazzi
M. Volpe
A. Zanchetti
C. Zoccali
SATELLITE LECTURE
Supported by Sanofi
Chairman: G. Deferrari
MEDICAL TREATMENT OF HYPERPHOSPHOREMIA
IN THE CKD PATIENT - A. Bellasi
SATELLYTE SYMPOSIUM
Supported by Menarini
Chairmen: C. Borghi, R. Pontremoli
CHRONIC HYPERURICEMIA WITH AND WITHOUT
URATE DEPOSITION AND CARDIORENAL RISK: FROM
PATHOGENETIC INSIGHTS TO THERAPEUTICS TARGETS
• Pathogenetic mechanisms
of cardiorenal damage - F. Viazzi
• Treatment of mild hyperuricemia:
is time to act? - G. Desideri
13.30
Working Lunch served in the foyer
14.30
LECTURE SESSION
Chairman: C. Zoccali
• Salt under the skin: Hypertension,
cardiovascular disease and osmotic
sodium accumulation - J.M. Titze
15.15
ROUND TABLE
Chairmen: G. Deferrari, P. Messa
THE UNIVERSITY HOSPITAL TODAY AND
TOMORROW:
AT THE CROSSROAD BETWEEN ACADEMIC MISSION
Brescia
Bologna
Paris (France)
Como
Bologna
Napoli
Genova
L’Aquila
Catania
L’Aquila
Padova
Bari
Milano
Lecco
Paris (France)
Milano
Milano
Milano
Roma
Brescia
Pisa
Genova
Milano
Genova
Pisa
Bologna
Perugia
Milano
Pisa
Torino
Erlangen (Germany)
Napoli
Genova
Roma
Milano
Reggio Calabria
17.30
SATELLITE LECTURE
Supported by MSD
Chairman: S. Taddei
HYPERLIPEMIA TREATMENT IN CHRONIC KIDNEY DISEASE
PATIENT: FROM SHARP TRIAL TO NOTA 13 - R. Pontremoli
18.00
LECTURE SESSION
Chairmen: G. Capasso, A. Santoro
• New and less new Erythropoietin
Stimulating Agents: an update - F. Locatelli
• The EVOLVE trial: shades, lights
and where to go - G. London
NHS NEEDS
• Introduction - G. Deferrari
• The University and Research Ministry
point of view - S. Nuti
• The Health Ministry point of view - F. Moirano
AND THE
17.15
19.30
P ROGRAM
P r
09.00
LECTURE SESSION
Resistant Hypertension:
Medical Treatment Vs Intervention
Chairmen: C. Ferri, M. Volpe
• Drug therapy to achieve sequential
nephron block - M. Azizi
• Renal Denervation - A. Stella
10.00
LECTURE
Chairman: A. Salvetti
The problem of CV prevention: the “earlier”
or the “lower” is better? - C. Borghi
10.30
Coffee Break
11.00
LECTURE SESSION
Chairmen: E. Ambrosioni, A. Morganti
• Optimizing treatment strategies
in hypertension: should a diuretic
or calcium channel blockers be
preferred in combination with
an RAAS-Inhibitor? - M. Volpe
• Changes in subclinical organ damage: are
they really useful in the management of
hypertensive patients? - A. Zanchetti
12.30
Closing remarks
P r o g r a m
P ROGRAM
09.00
ROUND TABLE
Chairmen: E. Agabiti Rosei, B. Trimarco
NEW ESH-ESC GUIDELINES
• What’s new - G. Mancia
• What has been confirmed - E. Agabiti Rosei
11.00
Coffee Break
11.30
LECTURE SESSION
BP Monitoring and vascular stiffness
Chairmen: G. Grassi, M.L. Muiesan
• Usefulness of BP variability
in the clinical setting - G. Parati
• How to measure vascular stiffness,
and why should we care - G. Schillaci
o g r a m
Saturday, February 22, 2014
Welcome Cocktail
Friday, February 21, 2014
End of sessions